通过分子对接和分子动力学模拟,识别抑制NF-κBI诱导激酶的海洋化合物
Muhammad Yasir1, Jinyoung Park1, Eun-Taek Han2
1Department of Pharmacology, Kangwon National University School of Medicine, Chuncheon 24341, Republic of Korea.
Biomolecules
|January 8, 2025
概括
海洋化合物显示出作为NF-κB诱导激酶 (NIK) 的天然抑制剂的潜力,这是炎症和癌症的关键驱动因素. 圣克鲁萨马酸甲,桑托辛和阿克丁诺因表现出强烈的结合和稳定的相互作用,提供新的治疗途径.
科学领域:
- 生物化学和分子生物学
- 药理学和药物发现
- 海洋天然产品 化学 化学
背景情况:
- 诱导NF-κB激酶 (NIK) 对炎症和免疫反应至关重要,其失调与癌症和自身免疫性疾病等疾病有关.
- 尼克在正规和非正规NF-κB通路中的作用使其成为各种病理的重要治疗点.
- 海洋衍生化合物代表了新型治疗剂的大部分未开发资源.
研究的目的:
- 研究海洋衍生化合物作为NF-κB诱导激酶 (NIK) 抑制剂的潜力.
- 使用计算方法识别具有高结合亲和度和与NIK活性部位稳定的相互作用的特定海洋化合物.
- 探索这些海洋化合物对炎症性疾病和癌症的治疗影响.
主要方法:
- 利用集成计算技术,包括分子对接,分子动力学 (MD) 模拟和自由能量计算.
- 与NIK活跃站点对比生物活性海洋化合物的库.
- 分析了结合亲和力,相互作用稳定性和自由能量概况,以确定NIK抑制剂.
主要成果:
- 几种海洋化合物对NIK活性部位表现出强烈的结合亲和力.
- 圣克鲁萨马酸A,桑托辛和阿克丁因被确定为有前途的NIK抑制剂,表现出紧的结合和高度稳定的相互作用.
- 这些化合物显示出有利的自由能量概况,表明它们的潜在有效性.
结论:
- 海洋衍生化合物,特别是圣克鲁萨酸A,桑托辛和阿克丁诺宁,显示出作为NIK抑制剂的显著潜力.
- 这些发现支持对海洋天然产品的探索,以开发针对NIK的新型抗炎和抗癌疗法.
- 这项研究为基于天然产品的抗NIK介导疾病药物发现开辟了新的途径.
更多相关视频
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
494
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
9.1K
相关概念视频
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
MAPK Signaling Cascades
5.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K
Co-activators and Co-repressors
7.3K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.3K
